In Refractory Status Epilepticus, Lacosamide May Be a Good Option
In patients with lorazepam-resistant status epilepticus, treatment with lacosamide had comparable efficacy and safety as sodium valproate.
In patients with lorazepam-resistant status epilepticus, treatment with lacosamide had comparable efficacy and safety as sodium valproate.
On average, pediatric patients spent more time in the ICU and accounted for a larger hospitalization cost.
VEEG abnormalities were detected in 56.7% of patients, and these were a statistically significant predictor of recurring seizure.
Surprisingly, the authors found that change in VBR did not correlate with functional outcomes.
The mSTESS predicted mortality at a rate of 80.1%.
AES releases a new, evidence-based treatment guideline for convulsive status epilepticus, the most common form of the condition associated with substantial mortality.